2023-09-22 HC Andersen – Update on re-evaluation of Sparkle headline data Magnus Corfitzen gives an update on re-evaluation of Sparkle headline data
2023-09-12 Erik Penser Bank – Health Care Day Deputy CEO and CCO presents at Erik Penser Health Care day.
2023-08-23 HC Andersen – Half Year Report 2023 Chief Executive Officer presents at HC Andersen - Half Year Report 2023
2023-05-25 Erik Penser Bank – Company Day Chief Executive Officer presents at Erik Pensers Company Day
2023-03-30 HC Andersen – Orviglance commercial opportunity and progress towards launch Deputy Chief Executive Officer & CCO presents at HC Andersen
2023-02-16 HC Andersen – Q4 2022 highlights and Q&A Chief Executive Officer presents at HC Andersen - Q4 2022 highlights and Q&A
2022-05-31 HC Andersen – Oncology Seminar Chief Executive Officer presents at HC Andersen Oncology Seminar
2022-05-19 Erik Penser Bank – Company Day Chief Executive Officer presents at Erik Pensers Company Day
2022-04-27 Redeye Orphan Drug Day Chief Medical Officer, Carl Bjartmar presents at Redeye Orphan Drug Day
2022-02-24 Erik Penser Bank – Life Science day Chief Commercial Officer Julie Waras Brogren presents at Erik Pensers Life Science day
2022-01-31 Ascelia Pharma – Aktiedagen in Lund 2022 Chief Commercial Officer presents at Aktiedagen in Lund
2022-01-20 Redeye Fight Cancer Seminar 2022 VP of R&D Andreas Norlin presents at Redeye Fight Cancer Seminar
2021-12-07 HC Andersen Capital seminar – Re-read Study Orviglance vs. Gadolinium CEO Magnus Corfitzen presents results from the re-read study vs. a gadolinium contrast agent (presentation in Danish)